636589-63-4Relevant articles and documents
Discovery, design and synthesis of Y-shaped peroxisome proliferator- activated receptor δ agonists as potent anti-obesity agents in vivo
Ham, Jungyeob,Hwang, Hoosang,Kim, Euno,Kim, Jeong-Ah,Cho, Sung Jin,Ko, Jaeyoung,Lee, Woojin,Lee, Jaehwan,Holla, Harish,Banerjee, Joydeep,Kim, Seokho,Yang, Inho,Lee, Hyun Joo,Shin, Kyoungjin,Choi, Hyukjae,Nam, Sang-Jip,Tak, Jungae,Hahn, Dongyup,Oh, Taekyung,Won, Dong Hwan,Lee, Tae Gu,Choi, Jihye,Park, Mi Sun,Seok, Chaok,Chin, Jungwook,Kang, Heonjoong
experimental part, p. 190 - 202 (2012/08/13)
We have discovered and demonstrated the in vitro and in vivo PPARδ-selective activity of novel Y-shaped agonists. These compounds activated hPPARδ with EC50 values between 1 and 523 nM. Surprisingly, compounds 10a, 11d, 11e and 11f were the mos
THIAZOLE COMPOUND (AS PPARδ) LIGAND AND PHARMACEUTICAL, COSMETIC AND HEALTH FOOD COMPRISED THEREOF
-
Page/Page column 10; 25-26, (2008/12/07)
The present invention relates to a thiazole compound as a peroxisome proliferator activated receptor δ (PPARδ) activator or pharmaceutically acceptable salts thereof, and a pharmaceutical composition, a functional cosmetic composition, a health food, health beverages, a food additive and animal feeds containing the same.
A highly efficient synthesis of antiobestic ligand GW501516 for the peroxisome proliferator-activated receptor δ through in situ protection of the phenol group by reaction with a Grignard reagent
Ham, Jungyeob,Kang, Heonjoong
, p. 6683 - 6686 (2007/10/03)
A new synthesis of an agonist for the peroxisome proliferator-activated receptor δ (PPARδ) GW501516 as a potential antiobesity drug is described. The synthetic route involves the in situ protection of the phenol group with a Grignard reagent and a regio-controlled one-pot reaction for the formation of a sulfide bond as the key step. Starting from commercially available 4-iodo-2-methylphenol, this approach affords GW501516 with an overall yield of 87%.